Kari B. Wisinski
- Oncology top 2%
- Molecular Biology top 10%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Biomedical Engineering top 10%
- Co-authors
- Anita TurkWei XuDavid J. BeebeRuth O’ReganMelissa C. SkalaJosé M. AyusoMurtuza RampurwalaWei Huang
- Topics
- Advanced Breast Cancer Therapies (21 papers)Cancer Treatment and Pharmacology (18 papers)HER2/EGFR in Cancer Research (16 papers)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Kari B. Wisinski
80 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 110
- Oncology 987
- Molecular Biology 803
- Cancer Research 426
- Pulmonary and Respiratory Medicine 340
- Biomedical Engineering 255
Countries citing papers authored by Kari B. Wisinski
This map shows the geographic impact of Kari B. Wisinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari B. Wisinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari B. Wisinski more than expected).
Fields of papers citing papers by Kari B. Wisinski
This network shows the impact of papers produced by Kari B. Wisinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari B. Wisinski. The network helps show where Kari B. Wisinski may publish in the future.
Co-authorship network of co-authors of Kari B. Wisinski
This figure shows the co-authorship network connecting the top 25 collaborators of Kari B. Wisinski. A scholar is included among the top collaborators of Kari B. Wisinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kari B. Wisinski. Kari B. Wisinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 10 | |
| 6 | 2 | |
| 7 | 2 | |
| 8 | 41 | |
| 9 | 20 | |
| 10 | 84 | |
| 11 | 155 | |
| 12 | 27 | |
| 13 | 19 | |
| 14 | 48 | |
| 15 | 40 | |
| 16 | 20 | |
| 17 | 204 | |
| 18 | 17 | |
| 19 | 14 | |
| 20 | 19 |
About Kari B. Wisinski
Kari B. Wisinski is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 93 papers that have together received 1.9k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (21 papers), Cancer Treatment and Pharmacology (18 papers) and HER2/EGFR in Cancer Research (16 papers). The work is most often cited by research in Oncology (987 citations), Cancer Research (426 citations) and Molecular Biology (803 citations). Kari B. Wisinski has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Anita Turk, Wei Xu, David J. Beebe, Ruth O’Regan, Melissa C. Skala, José M. Ayuso, Murtuza Rampurwala, Wei Huang, Menggang Yu and Amyé Tevaarwerk. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.